Impaired rapid mineralocorticoid action on free intracellular calcium in pseudohypoaldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 831-834

  Gamarra, Fernando ^b   Simic Schleicher, Gunter ^c   Huber, Rudolf M ^b   Ulsenheimer, Axel ^b   Scriba, Peter C ^b   Kuhnle, Ursula ^b   Wehling, Martin ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM CHANNEL; CALCIUM ION; FURA 2 ACETOXYMETHYL ESTER; MINERALOCORTICOID RECEPTOR; POTASSIUM ION; RENIN; SODIUM CHANNEL; SODIUM ION;

ALDOSTERONE BLOOD LEVEL; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; NOSE MUCOSA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; RECEPTOR BINDING;

ADULT; ALDOSTERONE; CALCIUM; CELLS, CULTURED; FEMALE; FURA-2; HUMANS; INFANT; INTRACELLULAR MEMBRANES; MALE; NASAL MUCOSA; PSEUDOHYPOALDOSTERONISM;

EID: 0031016973     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.831     Document Type: Article

References (24)

1. Cheek DB, Perry JW. 1958 A salt wasting syndrome in infancy. Arch Dis Child. 33:252-256.
2. Wehling M, Armanini D, Strasser T, Weber PC. 1987 Effect of aldosterone on the sodium and potassium concentrations in human mononuclear leukocytes. Am J Physiol. 252:E505-E508.
3. Wehling M, Käsmayr J, Theisen K. 1990 Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro. Cell Calcium. 11:565-571.
4. Wehling M, Kuhls S, Armanini D. 1989 Volume regulation of human lymphocytes by aldosterone in isotonic media. Am J Physiol. 257:E170-E174.
5. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. 1995 Rapid non-genomic effects of aldosterone on sodium transport in rat vascular smooth muscle cells: involvement of the Na+/H+-antiport. Hypertension. 25:117-123.
6. Wehling M, Käsmayr J, Theisen K. 1989 Fast effects of aldosterone on electrolytes in human lymphocytes are mediated by the sodium-proton-exchanger of the cell membrane. Biochem Biophys Res Comm. 164:961-967.
7. Wehling M, Käsmayr J, Theisen K. 1991 Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or non-genomic pathway? Am J Physiol. 260:E719-E726.
8. Christ M, Sippel K, Eisen C, Wehling M. 1994 Nonclassical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol. 99:R31-R34.
9. Wehling M, Christ M, Theisen K. 1992 Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol. 263:E974-E979.
10. Christ M, Eisen C, Aktas J, Theisen K, Wehling M. 1993 The inositol-1,4,5-trisphosphate system is involved in rapid non-genomic effects of aldosterone in human mononuclear leukocytes. J Clin Endocrinol Metab. 77:1452-1457.
11. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. 1995 Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res. 76:973-979.
12. Armanini D, Kuhnle U, Strasser T, et al. 1985 Pseudohypoaldosteronism: demonstration of aldosterone receptor deficiency. N Engl J Med. 313: 1178-1181.
13. Arai K, Tsigos C, Suzuki Y, et al. 1994 Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab. 79:1019-1023.
14. Komesaroff PA, Verity K, Fuller PJ. 1994 Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor. J Clin Endocrinol Metab. 79:27-31.
15. Zennaro MC, Borensztein P, Jeunemaitre X, Armanini D, Soubrier F. 1994 No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J Clin Endocrinol Metab. 79:32-38.
16. Wehling M, Kuhnle U, Weber PC, Armanini D. 1988 Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leukocytes from patients with pseudohypoaldosteronism. Clin Endocrinol (Oxf). 28:67-74.
17. Wehling M, Kuhnle U, Keller U, Weber PC, Armanini D. 1989 Inheritance of mineralocorticoid effector abnormalities of human mononuclear leukocytes in families with pseudohypoaldosteronism. Clin Endocrinol (Oxf). 31:597-605.
18. Chang SS, Grunder S, Hanukoglu A, et al. 1996 Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. 12:248-253.
19. Kuhnle U, Hinkel GK, Akkurt HI, Krozowski Z. 1995 Familial autosomal pseudohypoaldosteronism: A review on the heterogeneity of the syndrome. Steroids. 60:157-160.
20. Simic-Schleicher G, Kuhnle U. 1996 Familial autosomal dominant pseudohypoaldosteronism: Biochemical variability after stimulation with furosemide. Horm Res 46 [Suppl 2]:8.
21. Wu R, Yankaskas J, Cheng E, Knowles MR, Boucher R. 1985 Growth and differentiation of human nasal epithelial cells in culture. Am Rev Respir Dis. 132:311-320.
22. Grynkiewicz G, Poenie M, Tsien RY. 1985 generation of Ca indicators with greatly improved fluorescence properties. J Biol Chem. 260:3440-3450.
23. Wehling M, Kuhls S, Kuhnle U, Theisen K. 1990 Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension. Klin Wochenschr. 68:71-76.
24. Wehling M, Kuhls S, Witzgall H, Kuhnle U, Armanini D, Theisen K. 1987 Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism. Acta Endocrinol (Kbh) 116:555-560.